Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters
Wen Su(University of Hong Kong), Adrianus C. M. Boon, Houda Harastani(Washington University in St. Louis), Ali H. Ellebedy(Washington University in St. Louis), John M. Nicholls(University of Hong Kong), Hui‐Ling Yen(University of Hong Kong), Zhuoming Liu(Washington University in St. Louis), Aaron J. Schmitz(Washington University in St. Louis), Traci L. Bricker(Washington University in St. Louis), Alvina Y. L. Wong(University of Hong Kong), Bassem M. Mohammed(Washington University in St. Louis), Sin Fun Sia(Pennsylvania State University), Jackson S. Turner(Washington University in St. Louis), Ka Man Cheng(University of Hong Kong), Astha Joshi(Washington University in St. Louis), Allison J. Greaney(University of Washington), Sean P. J. Whelan(University of Pittsburgh Medical Center), Jesse D. Bloom(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Tamarand L. Darling(Washington University in St. Louis), Ka Tim Choy(University of Hong Kong), Tyler N. Starr(University of Utah)
Cited by 21
Related Papers
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
|Nature|2020|1.5k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
|Cell Host & Microbe|2021|851